McClure, David L <br/><br/>
Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present.  [electronic resource] 

 -  Pharmacoepidemiology and drug safety  Feb 2007 
 - 132-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1053-8569 
<br/><br/><label>Standard No.: </label>10.1002/pds.1341  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Muscular Diseases--chemically induced<br/>Myositis--chemically induced<br/>Odds Ratio<br/>Randomized Controlled Trials as Topic--methods<br/>Research Design<br/>Rhabdomyolysis--chemically induced<br/>Risk Assessment